The market for biopharmaceutical products has been expanding rapidly for several years.
This inevitably applies ever-increasing pressure on cost control, competitiveness and flexibility, the latter being crucial in an industry where the acceleration of development and scale-up cycles is a key success driver. Biopharma companies must also comply with stringent product quality and safety requirements, as well as strict regulatory frameworks, not forgetting increased competitive pressure with the emergence of biosimilar products.
All industry players are therefore constantly looking for new ways to optimise their production processes (bioprocesses) to make them not only more productive and profitable, but also safer and more flexible. This is generally referred to as process intensification.
We have dedicated a series of 5 webinars on Downstream Process Intensification. Join us to discover how BioSC™ Predict can switch from Batch to Multi-Column Chromatography.
Meet our speakers
Thomas Flouquet, Product Manager, Novasep Equipment Solutions.